InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,745.37
(
0.40%
)
US TECH 100
19,584.40
(
0.78%
)
Dow Jones
42,175.11
(
0.62%
)
Brent Oil
70.86
(
-3.19%
)
Bitcoin
64,726.35
(
2.53%
)
Post# of 253237
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biopa

Send PM Follow Ignore
Followers 13
Posts 846
Boards Moderated 0
Alias Born 01/29/2013

biopa

Re: None

Friday, 07/12/2013 5:03:53 PM

Friday, July 12, 2013 5:03:53 PM

Post# of 253237
MNKD Question for Dew
At a recent conference one of the MNKD officers stated that the FDA had no problem with safety or efficacy of Afreeza but had a problem with the delivery applicator. MNKD has simplified the applicator and I'm sure has tested that it delivers the same dosage. In your opinion, is the above factual? If this is the case the outlook for MNKD should be very exciting. Am I overlooking some facts or simplifying this too much?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up